50 results on '"Ambrosino, Donna"'
Search Results
2. Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial
3. Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
4. CD209L (L-SIGN) Is a Receptor for Severe Acute Respiratory Syndrome Coronavirus
5. SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.
6. Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.
7. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates
8. Therapy with a Severe Acute Respiratory Syndrome-Associated Coronavirus-Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters
9. Development and Characterization of a Severe Acute Respiratory Syndrome-Associated CoronavirusNeutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice [with Discussion]
10. Normal IgG and Impaired IgM Responses to Polysaccharide Vaccines in Asplenic Patients
11. Reduction of Respiratory Syncytial Virus (RSV) in Tracheal Aspirates in Intubated Infants by Use of Humanized Monoclonal Antibody to RSV F Protein
12. Pneumococcal Conjugate Vaccine Primes for Antibody Responses to Polysaccharide Pneumococcal Vaccine after Treatment of Hodgkin's Disease
13. Treatment with monoclonal antibodies against clostridium difficile toxins
14. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates
15. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins
16. Immunogenicity of SCB-2019 Coronavirus Disease 2019 Vaccine Compared With 4 Approved Vaccines.
17. Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice
18. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
19. Evidence for antibody as a protective correlate for COVID-19 vaccines.
20. Effect of monophosphoryl lipid A (MPL ®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM 197 conjugate vaccine in healthy toddlers
21. Antibody Responses to Polysaccharide and Polysaccharide-Conjugate Vaccines after Treatment of Hodgkin Disease
22. Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
23. Antibody Response of Infants to Haemophilus influenzae Type b Capsular Polysaccharide Combined with Bordetella pertussis
24. Passive Immunization against Disease Due to Haemophilus influenzae Type b: Concentrations of Antibody to Capsular Polysaccharide in High-Risk Children
25. Simultaneous Administration of Vaccines for Haemophilus influenzae Type b, Pneumococci, and Meningococci
26. κ and λ Light Chain Composition of Antibody to the Capsular Polysaccharide of Haemophilus influenzae Type b
27. Blood-Group-A-Like Substance in a Preparation of Pneumococcal Vaccine
28. History of passive antibody administration for prevention and treatment of infectious diseases.
29. High-Throughput Sequencing Analysis of Post-Liver Transplantation HCV E2 Glycoprotein Evolution in the Presence and Absence of Neutralizing Monoclonal Antibody.
30. Identification of Human Monoclonal Antibodies Specific for Human SOD1 Recognizing Distinct Epitopes and Forms of SOD1.
31. Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees.
32. Enzyme-linked immunosorbent assay to assess respiratory syncytial virus concentration and correlate results with inflammatory mediators in tracheal secretions.
33. IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants.
34. POLYSACCHARIDE CONJUGATE VACCINE RESPONSES IN BONE MARROW TRANSPLANT PATIENTS1.
35. Haemophilus influenzae type b unsuspected bacteremia.
36. 751b Phase II Efficacy of Human Monoclonal Antibody Treatment to Prevent C. difficile Recurrence
37. RESPIRATORY SYNCYTIAL VIRUS VACCINES.
38. Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels
39. Impaired antibody responses in the hyperimmunoglobulin E syndrome
40. Response to Haemophilus influenzae type B conjugate vaccine in children undergoing splenectomy
41. Recombinant Interleukin-2 Infusions and Decreased IgG2 Subclass Concentrations
42. Towards a population-based threshold of protection for COVID-19 vaccines.
43. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
44. Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus.
45. Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with Receptor.
46. Effect of monophosphoryl lipid A (MPL®) on T-helper cells when administered as an adjuvant with pneumocococcal–CRM197 conjugate vaccine in healthy toddlers
47. MANAGEMENT OF PERSISTENT CHYLOTHORAX
48. Straight talk with...Donna Ambrosino. Interview by Elie Dolgin.
49. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.
50. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile-induced mortality in hamsters.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.